Sort   by:  
 Page size 
UnknownEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219 | biostudies-literature
UnknownEfficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
Not available
S-EPMC8009612 | biostudies-literature
UnknownComparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial.
Not available
S-EPMC10448364 | biostudies-literature
UnknownA Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Not available
S-EPMC7781100 | biostudies-literature
UnknownAusTraits, a curated plant trait database for the Australian flora.
Not available
S-EPMC8484355 | biostudies-literature
UnknownCorrelates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.
Not available
S-EPMC8604724 | biostudies-literature
UnknownReactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Not available
S-EPMC8409975 | biostudies-literature
UnknownCHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.
Not available
S-EPMC6218476 | biostudies-literature
UnknownSafety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Not available
S-EPMC7445431 | biostudies-literature
UnknownOutpatient hospital attendances in people with rheumatoid arthritis during the COVID-19 pandemic and beyond: a cohort study in three nations of the UK.
Not available
S-EPMC12862379 | biostudies-literature
Sort   by:  
 Page size